“Compare suppliers above. Sort by price, purity, or supplier rating. Add lines from any vendor to one cart.”— PEPVERA · marketplace


Larazotide
Tight-junction stabilizer.
- Sizes available
- 10mg
- Tested by
- self-test (HPLC + mass spec) (ISO 17025 lab)
- Purity
- 99.17352% (HPLC)
- Batch ID
- SWI-LAR-10
- Made
- April 2026
- Expires
- April 2027
- Suppliers selling this
- 10
The molecule, plainly.
Mechanism, target dose, ramp, and risks — sourced from the supplier's documented protocol.
- Mechanism
- Gut tight-junction modulator. Studied for celiac.
- Target dose
- 0.5 mg, oral, before meals.
- Ramp
- Daily.
- Risks
- Trial-stage data.
Draw 20 units.
1 mg = 0.20 mL at 5.00 mg/mL. 10.0 doses per vial.
Week 1
0.5 mg, oral, before meals.
Begin near site
Week 2–4
0.5 mg, oral, before meals.
Daily, rotate
Week 5–6
0.5 mg, oral, before meals.
Taper option
Week 7+
Maintenance
As needed
Sourced from public discussion. Anonymized. Original wording preserved. Customers may submit a Field Report after delivery; curated entries appear above with the verified ordinal.
Verified by Janoshik
ISO 17025
Independent third-party HPLC and mass spectrometry on every batch.
Refund on unopened
thirty days
Full refund within thirty days on any unopened vial. No questions.
Replacement on damage
cold-chain
Insulated express. If a vial arrives warm or broken, full replacement.
Direct from foundry. Slower than domestic resellers; consistency is the trade. Insulated packaging, tracked from departure to doorstep. Replacement issued on damage.
Gut tight-junction modulator. Studied for celiac.
Research-grade peptide. Sold for laboratory use only — not for human consumption.
repair · V · SwissChems
Larazotide · 10mg